ConductScience.org, home

Gene · 2213

NIH grants2,625

NIH grants whose papers are about the gene, through NIH's grant-paper links.

601 to 620 of 2,625

Download this page as JSON
GrantTitleFCGR2B papersNewest fiscal year
T32AI007632HIV Pathogenesis, Vaccination and Cure12024
T32AI052077Basic Immunology Training Program12024
T32CA060397Postdoctoral Training in Head and Neck Oncology12024
T32CA078207Training Program in Cancer Biology12024
T32GM007267Medical Scientist Training Program12024
T32GM008361Medical Scientist Training Program12024
T32GM008716TRAINING PROGRAM FOR MEDICAL SCIENTISTS12024
T32GM080202Medical Scientist Training Program12024
TL1TR001431Translational Biomedical Science Training Grant12024
TL1TR001451NRSA Training Core12024
U01AI148114Composition and structure of antibody receptors at the surface of primary human cells during immune activation12024
U01AI148153The immune regulation of macrophage antibody dependent cellular phagocytosis12024
U01AI150741Computational models of naturally acquired immunity to falciparum malaria12024
U01AI151788American and Asian Centers for Arboviral Research and Enhanced Surveillance (A2CARES)12024
U01CA195547The St. Jude Lifetime Cohort12024
U19AI090959Genetically-engineered pig organ transplantation in baboons: immunological and functional studies12024
U19AI142596Messenger RNA Immunogens for initiation of protective HIV non-neutralizing antibodies12024
U54CA260492Johns Hopkins Excellence in Pathogenesis and Immunity Center for SARS-CoV-2 (JH-EPICS)12024
U54CA260543North Carolina Seronet Center for Excellence12024
U54CA260581Tulane University COVID Antibody and Immunity Network (TUCAIN) Supplement12024

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/2213/grants?page=31